Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:methylenedioxypyrovalerone'
(id=7953714 ; fe=en:methylenedioxypyrovalerone ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=11965.875 creation date=2017-07-18 touchdate=2026-01-06 13:08:07.000)
≈ 70 relations sortantes

  1. en:methylenedioxypyrovalerone -- r_has_conseq #41: 706 / 1 -> en:vasoconstriction
    n1=en:methylenedioxypyrovalerone | n2=en:vasoconstriction | rel=r_has_conseq | relid=41 | w=706
  2. en:methylenedioxypyrovalerone -- r_has_conseq #41: 706 / 1 -> vasoconstriction
    n1=en:methylenedioxypyrovalerone | n2=vasoconstriction | rel=r_has_conseq | relid=41 | w=706
  3. en:methylenedioxypyrovalerone -- r_has_conseq #41: 639 / 0.905 -> anxiété
    n1=en:methylenedioxypyrovalerone | n2=anxiété | rel=r_has_conseq | relid=41 | w=639
  4. en:methylenedioxypyrovalerone -- r_has_conseq #41: 634 / 0.898 -> insomnie
    n1=en:methylenedioxypyrovalerone | n2=insomnie | rel=r_has_conseq | relid=41 | w=634
  5. en:methylenedioxypyrovalerone -- r_has_conseq #41: 633 / 0.897 -> psychose
    n1=en:methylenedioxypyrovalerone | n2=psychose | rel=r_has_conseq | relid=41 | w=633
  6. en:methylenedioxypyrovalerone -- r_has_conseq #41: 633 / 0.897 -> psychose
    (trouble mental)
    n1=en:methylenedioxypyrovalerone | n2=psychose
    (trouble mental)
    | rel=r_has_conseq | relid=41 | w=633
  7. en:methylenedioxypyrovalerone -- r_has_conseq #41: 631 / 0.894 -> euphorie
    n1=en:methylenedioxypyrovalerone | n2=euphorie | rel=r_has_conseq | relid=41 | w=631
  8. en:methylenedioxypyrovalerone -- r_has_conseq #41: 628 / 0.89 -> hypertension artérielle
    n1=en:methylenedioxypyrovalerone | n2=hypertension artérielle | rel=r_has_conseq | relid=41 | w=628
  9. en:methylenedioxypyrovalerone -- r_has_conseq #41: 613 / 0.868 -> en:generalized anxiety disorder
    n1=en:methylenedioxypyrovalerone | n2=en:generalized anxiety disorder | rel=r_has_conseq | relid=41 | w=613
  10. en:methylenedioxypyrovalerone -- r_has_conseq #41: 425 / 0.602 -> en:paranoia
    n1=en:methylenedioxypyrovalerone | n2=en:paranoia | rel=r_has_conseq | relid=41 | w=425
  11. en:methylenedioxypyrovalerone -- r_has_conseq #41: 365 / 0.517 -> paranoïa
    n1=en:methylenedioxypyrovalerone | n2=paranoïa | rel=r_has_conseq | relid=41 | w=365
  12. en:methylenedioxypyrovalerone -- r_has_conseq #41: 360 / 0.51 -> tachycardie
    n1=en:methylenedioxypyrovalerone | n2=tachycardie | rel=r_has_conseq | relid=41 | w=360
  13. en:methylenedioxypyrovalerone -- r_has_conseq #41: 138 / 0.195 -> vaso-constriction
    n1=en:methylenedioxypyrovalerone | n2=vaso-constriction | rel=r_has_conseq | relid=41 | w=138
  14. en:methylenedioxypyrovalerone -- r_has_conseq #41: 131 / 0.186 -> hta
    n1=en:methylenedioxypyrovalerone | n2=hta | rel=r_has_conseq | relid=41 | w=131
  15. en:methylenedioxypyrovalerone -- r_has_conseq #41: 91 / 0.129 -> en:insomnia
    n1=en:methylenedioxypyrovalerone | n2=en:insomnia | rel=r_has_conseq | relid=41 | w=91
  16. en:methylenedioxypyrovalerone -- r_has_conseq #41: 84 / 0.119 -> en:sleeplessness
    n1=en:methylenedioxypyrovalerone | n2=en:sleeplessness | rel=r_has_conseq | relid=41 | w=84
  17. en:methylenedioxypyrovalerone -- r_has_conseq #41: 83 / 0.118 -> en:tachycardia
    n1=en:methylenedioxypyrovalerone | n2=en:tachycardia | rel=r_has_conseq | relid=41 | w=83
  18. en:methylenedioxypyrovalerone -- r_has_conseq #41: 70 / 0.099 -> en:African trypanosomiasis
    n1=en:methylenedioxypyrovalerone | n2=en:African trypanosomiasis | rel=r_has_conseq | relid=41 | w=70
  19. en:methylenedioxypyrovalerone -- r_has_conseq #41: 70 / 0.099 -> en:sleeping sickness
    n1=en:methylenedioxypyrovalerone | n2=en:sleeping sickness | rel=r_has_conseq | relid=41 | w=70
  20. en:methylenedioxypyrovalerone -- r_has_conseq #41: 70 / 0.099 -> maladie du sommeil
    n1=en:methylenedioxypyrovalerone | n2=maladie du sommeil | rel=r_has_conseq | relid=41 | w=70
  21. en:methylenedioxypyrovalerone -- r_has_conseq #41: 62 / 0.088 -> HTA
    n1=en:methylenedioxypyrovalerone | n2=HTA | rel=r_has_conseq | relid=41 | w=62
  22. en:methylenedioxypyrovalerone -- r_has_conseq #41: 60 / 0.085 -> hypertension
    n1=en:methylenedioxypyrovalerone | n2=hypertension | rel=r_has_conseq | relid=41 | w=60
  23. en:methylenedioxypyrovalerone -- r_has_conseq #41: 58 / 0.082 -> en:hypertension
    n1=en:methylenedioxypyrovalerone | n2=en:hypertension | rel=r_has_conseq | relid=41 | w=58
  24. en:methylenedioxypyrovalerone -- r_has_conseq #41: 54 / 0.076 -> en:high blood pressure
    n1=en:methylenedioxypyrovalerone | n2=en:high blood pressure | rel=r_has_conseq | relid=41 | w=54
  25. en:methylenedioxypyrovalerone -- r_has_conseq #41: 53 / 0.075 -> en:synchopexia
    n1=en:methylenedioxypyrovalerone | n2=en:synchopexia | rel=r_has_conseq | relid=41 | w=53
  26. en:methylenedioxypyrovalerone -- r_has_conseq #41: 52 / 0.074 -> en:African sleeping sickness
    n1=en:methylenedioxypyrovalerone | n2=en:African sleeping sickness | rel=r_has_conseq | relid=41 | w=52
  27. en:methylenedioxypyrovalerone -- r_has_conseq #41: 52 / 0.074 -> Maladie du sommeil
    n1=en:methylenedioxypyrovalerone | n2=Maladie du sommeil | rel=r_has_conseq | relid=41 | w=52
  28. en:methylenedioxypyrovalerone -- r_has_conseq #41: 51 / 0.072 -> battement rapide du coeur
    n1=en:methylenedioxypyrovalerone | n2=battement rapide du coeur | rel=r_has_conseq | relid=41 | w=51
  29. en:methylenedioxypyrovalerone -- r_has_conseq #41: 51 / 0.072 -> trouble anxieux généralisé
    n1=en:methylenedioxypyrovalerone | n2=trouble anxieux généralisé | rel=r_has_conseq | relid=41 | w=51
  30. en:methylenedioxypyrovalerone -- r_has_conseq #41: 51 / 0.072 -> trypanosomiase africaine
    n1=en:methylenedioxypyrovalerone | n2=trypanosomiase africaine | rel=r_has_conseq | relid=41 | w=51
  31. en:methylenedioxypyrovalerone -- r_has_conseq #41: 51 / 0.072 -> trypanosomose africaine
    n1=en:methylenedioxypyrovalerone | n2=trypanosomose africaine | rel=r_has_conseq | relid=41 | w=51
  32. en:methylenedioxypyrovalerone -- r_has_conseq #41: 50 / 0.071 -> tachycardie, hypertension, microphtalmie et hyperglycinurie
    n1=en:methylenedioxypyrovalerone | n2=tachycardie, hypertension, microphtalmie et hyperglycinurie | rel=r_has_conseq | relid=41 | w=50
  33. en:methylenedioxypyrovalerone -- r_has_conseq #41: 49 / 0.069 -> en:lack of sleep
    n1=en:methylenedioxypyrovalerone | n2=en:lack of sleep | rel=r_has_conseq | relid=41 | w=49
  34. en:methylenedioxypyrovalerone -- r_has_conseq #41: 49 / 0.069 -> HTA
    (hypertension artérielle)
    n1=en:methylenedioxypyrovalerone | n2=HTA
    (hypertension artérielle)
    | rel=r_has_conseq | relid=41 | w=49
  35. en:methylenedioxypyrovalerone -- r_has_conseq #41: 47 / 0.067 -> fréquence cardiaque élevée
    n1=en:methylenedioxypyrovalerone | n2=fréquence cardiaque élevée | rel=r_has_conseq | relid=41 | w=47
  36. en:methylenedioxypyrovalerone -- r_has_conseq #41: 42 / 0.059 -> en:tachyrhythmia
    n1=en:methylenedioxypyrovalerone | n2=en:tachyrhythmia | rel=r_has_conseq | relid=41 | w=42
  37. en:methylenedioxypyrovalerone -- r_has_conseq #41: 42 / 0.059 -> sommeil (maladie du)
    n1=en:methylenedioxypyrovalerone | n2=sommeil (maladie du) | rel=r_has_conseq | relid=41 | w=42
  38. en:methylenedioxypyrovalerone -- r_has_conseq #41: 42 / 0.059 -> troubles endormissement et maintien du sommeil
    n1=en:methylenedioxypyrovalerone | n2=troubles endormissement et maintien du sommeil | rel=r_has_conseq | relid=41 | w=42
  39. en:methylenedioxypyrovalerone -- r_has_conseq #41: 40 / 0.057 -> trouble endormissement et maintien du sommeil
    n1=en:methylenedioxypyrovalerone | n2=trouble endormissement et maintien du sommeil | rel=r_has_conseq | relid=41 | w=40
  40. en:methylenedioxypyrovalerone -- r_has_conseq #41: 40 / 0.057 -> trouble insomniaque
    n1=en:methylenedioxypyrovalerone | n2=trouble insomniaque | rel=r_has_conseq | relid=41 | w=40
  41. en:methylenedioxypyrovalerone -- r_has_conseq #41: 37 / 0.052 -> hyposomnie
    n1=en:methylenedioxypyrovalerone | n2=hyposomnie | rel=r_has_conseq | relid=41 | w=37
  42. en:methylenedioxypyrovalerone -- r_has_conseq #41: 36 / 0.051 -> insomnia
    n1=en:methylenedioxypyrovalerone | n2=insomnia | rel=r_has_conseq | relid=41 | w=36
  43. en:methylenedioxypyrovalerone -- r_has_conseq #41: 35 / 0.05 -> agrypnie
    n1=en:methylenedioxypyrovalerone | n2=agrypnie | rel=r_has_conseq | relid=41 | w=35
  44. en:methylenedioxypyrovalerone -- r_has_conseq #41: 35 / 0.05 -> manque de sommeil
    n1=en:methylenedioxypyrovalerone | n2=manque de sommeil | rel=r_has_conseq | relid=41 | w=35
  45. en:methylenedioxypyrovalerone -- r_has_conseq #41: 30 / 0.042 -> accélération du rythme cardiaque
    n1=en:methylenedioxypyrovalerone | n2=accélération du rythme cardiaque | rel=r_has_conseq | relid=41 | w=30
  46. en:methylenedioxypyrovalerone -- r_has_conseq #41: 29 / 0.041 -> en:african trypanosomiasis
    n1=en:methylenedioxypyrovalerone | n2=en:african trypanosomiasis | rel=r_has_conseq | relid=41 | w=29
  47. en:methylenedioxypyrovalerone -- r_has_conseq #41: 25 / 0.035 -> en:and hyperglycinuria
    n1=en:methylenedioxypyrovalerone | n2=en:and hyperglycinuria | rel=r_has_conseq | relid=41 | w=25
  48. en:methylenedioxypyrovalerone -- r_has_conseq #41: 25 / 0.035 -> en:microphtalmia
    n1=en:methylenedioxypyrovalerone | n2=en:microphtalmia | rel=r_has_conseq | relid=41 | w=25
  49. en:methylenedioxypyrovalerone -- r_has_conseq #41: 24 / 0.034 -> en:euphoria
    n1=en:methylenedioxypyrovalerone | n2=en:euphoria | rel=r_has_conseq | relid=41 | w=24
  50. en:methylenedioxypyrovalerone -- r_has_conseq #41: 19 / 0.027 -> Tachycardie
    n1=en:methylenedioxypyrovalerone | n2=Tachycardie | rel=r_has_conseq | relid=41 | w=19
  51. en:methylenedioxypyrovalerone -- r_has_conseq #41: 7 / 0.01 -> Hypertension artérielle
    n1=en:methylenedioxypyrovalerone | n2=Hypertension artérielle | rel=r_has_conseq | relid=41 | w=7
  52. en:methylenedioxypyrovalerone -- r_has_conseq #41: 6 / 0.008 -> en:free floating anxiety
    n1=en:methylenedioxypyrovalerone | n2=en:free floating anxiety | rel=r_has_conseq | relid=41 | w=6
  53. en:methylenedioxypyrovalerone -- r_has_conseq #41: 5 / 0.007 -> Anxiété généralisée
    n1=en:methylenedioxypyrovalerone | n2=Anxiété généralisée | rel=r_has_conseq | relid=41 | w=5
  54. en:methylenedioxypyrovalerone -- r_has_conseq #41: 5 / 0.007 -> exhilaration
    n1=en:methylenedioxypyrovalerone | n2=exhilaration | rel=r_has_conseq | relid=41 | w=5
  55. en:methylenedioxypyrovalerone -- r_has_conseq #41: 4 / 0.006 -> anxiété généralisée
    n1=en:methylenedioxypyrovalerone | n2=anxiété généralisée | rel=r_has_conseq | relid=41 | w=4
  56. en:methylenedioxypyrovalerone -- r_has_conseq #41: 4 / 0.006 -> en:agrypnia
    n1=en:methylenedioxypyrovalerone | n2=en:agrypnia | rel=r_has_conseq | relid=41 | w=4
  57. en:methylenedioxypyrovalerone -- r_has_conseq #41: 4 / 0.006 -> en:arterial hypertension
    n1=en:methylenedioxypyrovalerone | n2=en:arterial hypertension | rel=r_has_conseq | relid=41 | w=4
  58. en:methylenedioxypyrovalerone -- r_has_conseq #41: 4 / 0.006 -> en:exhilaration
    n1=en:methylenedioxypyrovalerone | n2=en:exhilaration | rel=r_has_conseq | relid=41 | w=4
  59. en:methylenedioxypyrovalerone -- r_has_conseq #41: 3 / 0.004 -> IPCV
    n1=en:methylenedioxypyrovalerone | n2=IPCV | rel=r_has_conseq | relid=41 | w=3
  60. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> agression sexuelle (adulte victime d'une)
    n1=en:methylenedioxypyrovalerone | n2=agression sexuelle (adulte victime d'une) | rel=r_has_conseq | relid=41 | w=1
  61. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> en:ahypnia
    n1=en:methylenedioxypyrovalerone | n2=en:ahypnia | rel=r_has_conseq | relid=41 | w=1
  62. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> en:ahypnosis
    n1=en:methylenedioxypyrovalerone | n2=en:ahypnosis | rel=r_has_conseq | relid=41 | w=1
  63. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> en:GAD
    n1=en:methylenedioxypyrovalerone | n2=en:GAD | rel=r_has_conseq | relid=41 | w=1
  64. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> en:insomnolence
    n1=en:methylenedioxypyrovalerone | n2=en:insomnolence | rel=r_has_conseq | relid=41 | w=1
  65. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> en:nelavan
    n1=en:methylenedioxypyrovalerone | n2=en:nelavan | rel=r_has_conseq | relid=41 | w=1
  66. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> en:pervigilium
    n1=en:methylenedioxypyrovalerone | n2=en:pervigilium | rel=r_has_conseq | relid=41 | w=1
  67. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> en:sleep deprivation
    n1=en:methylenedioxypyrovalerone | n2=en:sleep deprivation | rel=r_has_conseq | relid=41 | w=1
  68. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> en:tachysystole
    n1=en:methylenedioxypyrovalerone | n2=en:tachysystole | rel=r_has_conseq | relid=41 | w=1
  69. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> hypertélorisme, hypospadias, polysyndactylie (syndrome)
    n1=en:methylenedioxypyrovalerone | n2=hypertélorisme, hypospadias, polysyndactylie (syndrome) | rel=r_has_conseq | relid=41 | w=1
  70. en:methylenedioxypyrovalerone -- r_has_conseq #41: 1 / 0.001 -> HyperTension
    n1=en:methylenedioxypyrovalerone | n2=HyperTension | rel=r_has_conseq | relid=41 | w=1
≈ 0 relations entrantes

    Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
    Projet JeuxDeMots - url: http://www.jeuxdemots.org
    contact: mathieu.lafourcade@lirmm.fr